X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3993) 3993
Publication (803) 803
Book Review (33) 33
Book Chapter (11) 11
Conference Proceeding (10) 10
Dissertation (6) 6
Book / eBook (5) 5
Paper (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2551) 2551
humans (1952) 1952
index medicus (1934) 1934
male (1244) 1244
adenosine triphosphate - pharmacology (1093) 1093
rats (1084) 1084
atp (995) 995
receptors, purinergic p2 - metabolism (866) 866
pharmacology & pharmacy (796) 796
neurosciences (750) 750
purinergic p2 receptor antagonists (699) 699
mice (663) 663
female (630) 630
adenosine triphosphate - metabolism (595) 595
calcium - metabolism (591) 591
adenosine triphosphate - analogs & derivatives (571) 571
cells, cultured (562) 562
purinergic p2y receptor antagonists - pharmacology (527) 527
receptors, purinergic p2 - physiology (524) 524
dose-response relationship, drug (521) 521
adenosine diphosphate - pharmacology (462) 462
platelet aggregation inhibitors - pharmacology (459) 459
clopidogrel (442) 442
physiology (435) 435
extracellular atp (411) 411
cell biology (407) 407
in vitro techniques (405) 405
adenosine (402) 402
activation (391) 391
purinergic receptors (378) 378
rats, sprague-dawley (374) 374
p2y (366) 366
receptors (358) 358
ticlopidine - analogs & derivatives (353) 353
purinergic p2 receptor agonists (352) 352
platelet aggregation - drug effects (341) 341
rats, wistar (333) 333
biochemistry & molecular biology (327) 327
blood platelets - drug effects (323) 323
signal transduction (318) 318
receptors, purinergic p2 - drug effects (316) 316
receptors, purinergic p2y1 (311) 311
adenosine - pharmacology (310) 310
adenosine - analogs & derivatives (302) 302
receptors, purinergic p2 - genetics (299) 299
suramin - pharmacology (298) 298
uridine triphosphate - pharmacology (298) 298
p2y receptor (289) 289
expression (278) 278
pyridoxal phosphate - analogs & derivatives (278) 278
p2x receptors (276) 276
platelet aggregation inhibitors - therapeutic use (276) 276
pyridoxal phosphate - pharmacology (275) 275
biomedicine (271) 271
purinergic p2y receptor antagonists - therapeutic use (268) 268
middle aged (267) 267
signal transduction - drug effects (267) 267
cells (263) 263
adenosine diphosphate - analogs & derivatives (259) 259
release (256) 256
nucleotides (255) 255
receptor (254) 254
article (245) 245
blood platelets - metabolism (242) 242
enzyme inhibitors - pharmacology (242) 242
neurons (239) 239
p2y receptors (237) 237
physiological aspects (236) 236
ticagrelor (231) 231
cell line (230) 230
signal transduction - physiology (230) 230
calcium (228) 228
mice, inbred c57bl (226) 226
pharmacology/toxicology (224) 224
time factors (224) 224
inhibition (223) 223
ticlopidine - pharmacology (223) 223
inflammation (222) 222
hematology (220) 220
thionucleotides - pharmacology (220) 220
aged (219) 219
pharmacology (215) 215
receptors, purinergic p2y12 (212) 212
prasugrel (207) 207
p2x receptor (206) 206
cardiac & cardiovascular systems (205) 205
adult (203) 203
human physiology (199) 199
adenosine triphosphate (197) 197
peripheral vascular disease (192) 192
percutaneous coronary intervention (191) 191
analysis (184) 184
p2 receptors (180) 180
research (179) 179
purinergic receptor (175) 175
purinoceptors (175) 175
rodents (173) 173
neurons - metabolism (172) 172
patch-clamp techniques (171) 171
research article (170) 170
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3981) 3981
Japanese (39) 39
Chinese (7) 7
French (6) 6
Russian (6) 6
Portuguese (3) 3
Danish (2) 2
German (2) 2
Ukrainian (2) 2
Hungarian (1) 1
Italian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuropharmacology, ISSN 0028-3908, 05/2016, Volume 104, pp. 31 - 49
Pharmacological tool compounds are now available to define action at the adenosine (ARs), P2Y and P2X receptors. We present a selection of the most commonly... 
Nucleosides | GPCR | Agonists | Antagonists | Nucleotides | Ion channel | ATP | PROTEIN-COUPLED RECEPTORS | ALLOSTERIC MODULATION | NEUROSCIENCES | NEUROPATHIC PAIN | NUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE | IN-VIVO | ION-CHANNEL | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | PURINERGIC RECEPTOR | P2Y RECEPTOR | STRUCTURE-BASED DESIGN | Purinergic P1 Receptor Agonists - chemistry | Receptors, Purinergic P2Y - chemistry | Receptors, Purinergic P2X - chemistry | Humans | Purinergic P1 Receptor Agonists - pharmacology | Receptors, Purinergic P2Y - metabolism | Purinergic P1 Receptor Antagonists - therapeutic use | Purinergic P2Y Receptor Agonists - chemistry | Purinergic P2Y Receptor Agonists - therapeutic use | Structure-Activity Relationship | Purinergic P1 Receptor Agonists - therapeutic use | Chemistry, Pharmaceutical | Purinergic P1 Receptor Antagonists - pharmacology | Purinergic P2Y Receptor Agonists - pharmacology | Receptors, Purinergic P1 - chemistry | Animals | Purinergic Agents - chemistry | Purinergic Agents - therapeutic use | Receptors, Purinergic P2X - metabolism | Receptors, Purinergic P1 - metabolism | Purinergic Agents - pharmacology | Purinergic P1 Receptor Antagonists - chemistry | Prevention | Brain | Purines | Enzymes | Injuries | Chronic pain | Cancer | antagonists | nucleosides | agonists | ion channel | nucleotides
Journal Article
Purinergic Signalling, ISSN 1573-9538, 9/2012, Volume 8, Issue 3, pp. 419 - 436
The medicinal chemistry and pharmacology of the four subtypes of adenosine receptors (ARs) and the eight subtypes of P2Y receptors (P2YRs, activated by a range... 
Clinical trials, nucleosides | Neurosciences | Adenosine receptors | Human Physiology | P2Y receptors | Antagonists | Nucleotides | Biomedicine general | Biomedicine | GPCR structure | Cancer Research | Agonists | Pharmacology/Toxicology | PHYLOGENETIC ANALYSIS | A(2B) ADENOSINE | ANTAGONIST RECOGNITION | SITE-DIRECTED MUTAGENESIS | MUTATIONAL ANALYSIS | NEUROSCIENCES | NUCLEOTIDE RECEPTORS | INTERNATIONAL UNION | SUBTYPE SELECTIVITY | MOLECULAR RECOGNITION | PURINERGIC RECEPTORS | Receptors, G-Protein-Coupled - metabolism | Humans | Purinergic P2Y Receptor Agonists - therapeutic use | Purinergic P1 Receptor Agonists - therapeutic use | Purinergic P1 Receptor Antagonists - pharmacology | Receptors, Purinergic P1 - chemistry | Receptors, Purinergic P2 - chemistry | Drug Design | Receptors, G-Protein-Coupled - drug effects | Purinergic P2Y Receptor Antagonists - therapeutic use | Purinergic P2Y Receptor Antagonists - pharmacology | Purinergic P1 Receptor Agonists - chemistry | Purinergic P1 Receptor Agonists - pharmacology | Purinergic P1 Receptor Antagonists - therapeutic use | Purinergic P2Y Receptor Agonists - chemistry | Clinical Trials as Topic | Receptors, Purinergic P2 - drug effects | Purinergic P2Y Receptor Agonists - pharmacology | Animals | Purinergic P2Y Receptor Antagonists - chemistry | Receptors, Purinergic P2 - metabolism | Ligands | Receptors, Purinergic P1 - metabolism | Receptors, Purinergic P1 - drug effects | Receptors, G-Protein-Coupled - chemistry | Purinergic P1 Receptor Antagonists - chemistry | Glaucoma | Heart | Adenosine | Parkinson's disease | Psoriasis | Cystic fibrosis | Rheumatoid factor | Hepatitis | Alkaloids | Pyrimidines | Heterocyclic compounds | Emissions (Pollution) | Rheumatoid arthritis | Respiratory tract diseases | Eye diseases | G proteins | Diabetes | Ophthalmology | Kidney diseases | Hepatitis C | DNA-ligand interactions | Arrhythmia | Clinical trials | Ionizing radiation | Reperfusion | Ischemia | pyrimidines | Injuries | Movement disorders | Neurodegenerative diseases | Diabetes mellitus | Lung diseases | Pharmacology | Thrombosis | imaging | Stress | Purine P2Y receptors | purines | Hypoxia | Receptor mechanisms | ATP | Cancer | Pharmaceuticals | Original
Journal Article